Benjamin A. Thuma

845 total citations
5 papers, 75 citations indexed

About

Benjamin A. Thuma is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, Benjamin A. Thuma has authored 5 papers receiving a total of 75 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Organic Chemistry, 3 papers in Molecular Biology and 2 papers in Oncology. Recurrent topics in Benjamin A. Thuma's work include Diabetes Treatment and Management (2 papers), Hemoglobinopathies and Related Disorders (1 paper) and Pharmacological Receptor Mechanisms and Effects (1 paper). Benjamin A. Thuma is often cited by papers focused on Diabetes Treatment and Management (2 papers), Hemoglobinopathies and Related Disorders (1 paper) and Pharmacological Receptor Mechanisms and Effects (1 paper). Benjamin A. Thuma collaborates with scholars based in United States and China. Benjamin A. Thuma's co-authors include Thomas A. Brandt, Vincent Mascitti, Ralph P. Robinson, Raman Sharma, Catherine A. Hulford, Aaron Smith, Brian Samas, Tristan S. Maurer, Richard Lehner and Peter H. Thompson and has published in prestigious journals such as Tetrahedron Letters, Organic Process Research & Development and MedChemComm.

In The Last Decade

Benjamin A. Thuma

5 papers receiving 71 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Benjamin A. Thuma United States	3	38	25	22	17	16	5	75
Catherine A. Hulford United States	4	40 1.1×	16 0.6×	11 0.5×	12 0.7×	11 0.7×	4	60
Annie Pullockaran United States	5	92 2.4×	43 1.7×	21 1.0×	7 0.4×	4 0.3×	6	115
Attila Paczal Hungary	6	116 3.1×	36 1.4×	6 0.3×	2 0.1×	6 0.4×	13	165
Sophie Y. Lavergne United States	5	172 4.5×	30 1.2×	13 0.6×	5 0.3×		7	196
Len F. Lee United States	10	165 4.3×	45 1.8×	27 1.2×	4 0.2×	2 0.1×	13	214
Mingshu Wu United States	9	125 3.3×	44 1.8×	4 0.2×	9 0.5×	3 0.2×	25	163
Steve Bai United States	3	83 2.2×	41 1.6×	3 0.1×	6 0.4×	1 0.1×	5	168
Edward C. Kendall United States	7	48 1.3×	60 2.4×	68 3.1×	4 0.2×	6 0.4×	16	167
Guillaume Maitro France	8	304 8.0×	24 1.0×	9 0.4×	4 0.2×		9	344

Countries citing papers authored by Benjamin A. Thuma

Since Specialization

Citations

This map shows the geographic impact of Benjamin A. Thuma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin A. Thuma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin A. Thuma more than expected).

Fields of papers citing papers by Benjamin A. Thuma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin A. Thuma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin A. Thuma. The network helps show where Benjamin A. Thuma may publish in the future.

Co-authorship network of co-authors of Benjamin A. Thuma

This figure shows the co-authorship network connecting the top 25 collaborators of Benjamin A. Thuma. A scholar is included among the top collaborators of Benjamin A. Thuma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benjamin A. Thuma. Benjamin A. Thuma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Baldwin, Aaron F., Shawn Cabral, Jeffrey T. Kohrt, et al.. (2023). Route Optimization of the Non-covalent Modulator of Hemoglobin PF-07059013 for the Treatment of Sickle Cell Disease, Part I: From Discovery Synthesis to First Kilogram-Scale Manufacture. Organic Process Research & Development. 27(5). 854–865. 2 indexed citations

2.

Brandt, Thomas A., Catherine A. Hulford, Richard Lehner, et al.. (2014). Development of an Early-Phase Bulk Enabling Route to Sodium-Dependent Glucose Cotransporter 2 Inhibitor Ertugliflozin. Organic Process Research & Development. 18(1). 57–65. 32 indexed citations

3.

Mascitti, Vincent, Benjamin A. Thuma, Aaron Smith, et al.. (2012). On the importance of synthetic organic chemistry in drug discovery: reflections on the discovery of antidiabetic agent ertugliflozin. MedChemComm. 4(1). 101–111. 28 indexed citations

4.

Samas, Brian, Cathy Préville, Benjamin A. Thuma, & Vincent Mascitti. (2010). 2-[4-Chloro-3-(4-ethoxybenzyl)phenyl]-1,3-dithiane. Acta Crystallographica Section E Structure Reports Online. 66(6). o1386–o1386. 1 indexed citations

5.

Mascitti, Vincent, Ralph P. Robinson, Cathy Préville, et al.. (2010). Syntheses of C-5-spirocyclic C-glycoside SGLT2 inhibitors. Tetrahedron Letters. 51(14). 1880–1883. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact